Thymosin Alpha-1 vs Thymalin
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Ta1, Zadaxin
Thymosin alpha-1 (sold as Zadaxin, generic name thymalfasin) is a 28-amino-acid peptide originally isolated from the thymus gland, the organ that trains your immune system. Unlike most peptides in this space, it is a real, approved drug in over 35 countries for chronic hepatitis B and as an immune booster, though it has never been approved by the FDA in the United States. It has one of the larger human evidence bases of any peptide here, with trials in tens of thousands of patients.
Also: Thymic Factor, Thymus Extract
Thymalin is not a single peptide but a polypeptide complex extracted from calf thymus, developed in the Soviet and Russian peptide-bioregulator tradition associated with Vladimir Khavinson. It is used in Russia and several post-Soviet countries to correct immune deficiency and is promoted as a geroprotector, with claimed effects on T and B lymphocytes, infection rates and aging. Outside that region it has no FDA or EMA approval, and the strongest human data come from a small number of studies, several from the originating research groups.
Key Comparison Insights
- Thymosin Alpha-1 is categorized as Immune, while Thymalin is Bioregulators.
Detailed Comparison
| Attribute | Thymosin Alpha-1 | Thymalin |
|---|---|---|
| Category | Immune | Bioregulators |
| FDA Status | Not FDA Approved | Not FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | Thymosin alpha-1 works as an immune modulator rather than a stimulant, meaning it tries to rebalance the immune system rather than simply rev it up. It signals through toll-like receptors, particularly TLR9 and TLR2, on dendritic cells, which are the immune system's messengers. That signaling pushes naive T cells toward a Th1 (pathogen-fighting) profile, boosts natural killer cell activity, and improves antibody responses. At the same time it can promote regulatory T cells via the IDO pathway, which is why it is described as restoring balance: it can both wake up a sluggish immune response and dampen a dangerously overactive one. | Thymalin is a mixture of short peptides isolated from the thymus, the organ that trains immune T cells, and its identified active fractions include very short peptides such as the dipeptides EW and KE. The proposed mechanism is that these peptides act as epigenetic regulators, binding DNA and histone-associated regions to influence gene expression for cytokines, heat-shock proteins and cell differentiation. Through this, it is reported to restore the number and function of T and B lymphocytes and to support phagocytosis. Because it is a complex mixture rather than one defined molecule, its actions are best described as a broad immunomodulatory and proposed gene-regulatory effect rather than a single clean receptor interaction. |
| Common Dosing | 1.6 mg twice weekly 2-3x weekly | 10-20 mg daily for 5-10 days Daily during cycles |
| Administration | Subcutaneous injection | Intramuscular injection |
| Typical Duration | 6-12 months for hepatitis | 10-day cycles, 1-2 times yearly |
| Best Time to Take | Morning | Morning |
Possible Side Effects May vary by individual |
|
|
| Research Summary | This is one of the few peptides on this list with serious human trial data, but the results are mixed and worth reading honestly. Thymosin alpha-1 is approved and widely used for chronic hepatitis B, often alongside interferon, and decades of use give it a strong safety record across more than 30 trials and over 11,000 subjects. The standout area is sepsis, and the story there is a cautionary tale: the earlier ETASS trial (Critical Care, 2013) hinted at lower 28-day mortality (26 percent versus 35 percent), but the much larger, better-designed TESTS phase 3 trial (BMJ, 2025, 1,106 patients, double-blind and placebo-controlled) found no mortality benefit at all (23.4 versus 24.1 percent). It has also been studied as an add-on in certain cancers and in vaccine response, with weaker evidence. The honest summary: real drug, good safety, proven in hepatitis B, but several of its most-hyped uses did not survive a rigorous trial. | Most published work on thymalin comes from Russian groups, much of it by Khavinson and collaborators, and ranges from cell experiments to clinical reports. Reviews describe restoration of lymphocyte counts and function, reduced incidence of acute respiratory disease in elderly populations, and geroprotective effects in long-running observational and animal studies. A widely cited paper reported that long-term administration of thymus and pineal peptides was associated with reduced mortality in older subjects, and a more recent study examined thymalin for regulating immune status in severe COVID-19 in older patients. The body of evidence does include some randomized and placebo-controlled work, but trials are generally small, often single-region, and not independently replicated at the scale Western regulators expect. The fair reading is that thymalin has decades of use and supportive but methodologically limited human data, and that it remains unapproved and largely unstudied by independent groups outside its country of origin. |
Frequently Asked Questions: Thymosin Alpha-1 vs Thymalin
What is the difference between Thymosin Alpha-1 and Thymalin?
Thymosin Alpha-1 is a immune peptide that thymosin alpha-1 (sold as zadaxin, generic name thymalfasin) is a 28-amino-acid peptide originally isolated from the thymus gland, the organ that trains your immune system. unlike most peptides in this space, it is a real, approved drug in over 35 countries for chronic hepatitis b and as an immune booster, though it has never been approved by the fda in the united states. it has one of the larger human evidence bases of any peptide here, with trials in tens of thousands of patients. Thymalin is a bioregulators peptide that thymalin is not a single peptide but a polypeptide complex extracted from calf thymus, developed in the soviet and russian peptide-bioregulator tradition associated with vladimir khavinson. it is used in russia and several post-soviet countries to correct immune deficiency and is promoted as a geroprotector, with claimed effects on t and b lymphocytes, infection rates and aging. outside that region it has no fda or ema approval, and the strongest human data come from a small number of studies, several from the originating research groups. The main differences lie in their mechanisms of action and clinical applications.
Which is better, Thymosin Alpha-1 or Thymalin?
Neither is universally "better" - the choice depends on your specific goals. Thymosin Alpha-1 is typically used for immune purposes, while Thymalin is used for bioregulators. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can Thymosin Alpha-1 and Thymalin be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using Thymosin Alpha-1 and Thymalin together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.